M25 Weight loss has a significant impact on anti-fibrotic drug tolerance in patients with idiopathic pulmonary fibrosis

RDC Moon; E Barker; S Agnew; J Sutcliffe; A Kwok; LG Spencer

doi:10.1136/thoraxjnl-2017-210983.447

Article info

PDF

Idiopathic pulmonary fibrosis treatment update

M25 Weight loss has a significant impact on anti-fibrotic drug tolerance in patients with idiopathic pulmonary fibrosis

Free

Authors

RDC Moon Aintree University Hospital, Liverpool, UK PubMed articles Google scholar articles
E Barker Aintree University Hospital, Liverpool, UK PubMed articles Google scholar articles
S Agnew Aintree University Hospital, Liverpool, UK PubMed articles Google scholar articles
J Sutcliffe Aintree University Hospital, Liverpool, UK PubMed articles Google scholar articles
A Kwok Aintree University Hospital, Liverpool, UK PubMed articles Google scholar articles
LG Spencer Aintree University Hospital, Liverpool, UK PubMed articles Google scholar articles

Citation

Moon R, Barker E, Agnew S, et al

M25 Weight loss has a significant impact on anti-fibrotic drug tolerance in patients with idiopathic pulmonary fibrosis

Thorax 2017;72:A250.

Publication history

First published November 15, 2017.

Online issue publication

September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password